COVID-19 vaccination roll-out and uptake among refugees and migrants in Greece : a retrospective analysis of national vaccination routine data
Copyright © 2024 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved..
OBJECTIVES: Refugees and migrants (R&Ms) exhibited higher risk of COVID-19 infection, and higher mortality rates during the pandemic. Acknowledging these risks, R&Ms early in the pandemic were identified by WHO as a priority vaccination group in need of protection. The aim of this study was to assess the vaccination roll-out and uptake among R&Ms residing in Reception Identification Centers (RICs) and Reception Sites (RSs) in Greece, relative to the general population.
STUDY DESIGN: Nationwide observational study.
METHODS: Retrospective analysis of national vaccination routine data and population census data, collected and triangulated from multiple official/governmental sources. Weekly vaccine roll-out and uptake were calculated for the general Greek population and the R&M population, through the first year of the vaccination programme in Greece (December 2020-December 2021).
RESULTS: Vaccine roll-out among migrants in RICs/RSs started with a 22-week delay, compared to the general population. By the end of the first year of the vaccination programme in Greece in December 2021, the national vaccination uptake among registered R&Ms residing in official reception facilities was 27.3 % for 1st dose and 4.7 % for booster dose; considerably lower compared to the general population (69.5 % uptake for 1st dose, 64.7 % for 2nd dose, and 32.0 % for 3rd dose).
CONCLUSION: Delayed vaccine roll-out and low vaccine uptake among R&Ms in Greece are signs of low prioritisation and implementation failures in the R&M vaccination strategy. In face of future public health threats, lessons should be learned, and vaccine equity should be insured for all socially vulnerable and high-risk population groups.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:229 |
|---|---|
| Enthalten in: |
Public health - 229(2024) vom: 23. März, Seite 84-87 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Puchner, K P [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 26.03.2024 Date Revised 26.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.puhe.2024.01.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36902625X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36902625X | ||
| 003 | DE-627 | ||
| 005 | 20240326235556.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.puhe.2024.01.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1348.xml |
| 035 | |a (DE-627)NLM36902625X | ||
| 035 | |a (NLM)38412698 | ||
| 035 | |a (PII)S0033-3506(24)00030-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Puchner, K P |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a COVID-19 vaccination roll-out and uptake among refugees and migrants in Greece |b a retrospective analysis of national vaccination routine data |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.03.2024 | ||
| 500 | |a Date Revised 26.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a OBJECTIVES: Refugees and migrants (R&Ms) exhibited higher risk of COVID-19 infection, and higher mortality rates during the pandemic. Acknowledging these risks, R&Ms early in the pandemic were identified by WHO as a priority vaccination group in need of protection. The aim of this study was to assess the vaccination roll-out and uptake among R&Ms residing in Reception Identification Centers (RICs) and Reception Sites (RSs) in Greece, relative to the general population | ||
| 520 | |a STUDY DESIGN: Nationwide observational study | ||
| 520 | |a METHODS: Retrospective analysis of national vaccination routine data and population census data, collected and triangulated from multiple official/governmental sources. Weekly vaccine roll-out and uptake were calculated for the general Greek population and the R&M population, through the first year of the vaccination programme in Greece (December 2020-December 2021) | ||
| 520 | |a RESULTS: Vaccine roll-out among migrants in RICs/RSs started with a 22-week delay, compared to the general population. By the end of the first year of the vaccination programme in Greece in December 2021, the national vaccination uptake among registered R&Ms residing in official reception facilities was 27.3 % for 1st dose and 4.7 % for booster dose; considerably lower compared to the general population (69.5 % uptake for 1st dose, 64.7 % for 2nd dose, and 32.0 % for 3rd dose) | ||
| 520 | |a CONCLUSION: Delayed vaccine roll-out and low vaccine uptake among R&Ms in Greece are signs of low prioritisation and implementation failures in the R&M vaccination strategy. In face of future public health threats, lessons should be learned, and vaccine equity should be insured for all socially vulnerable and high-risk population groups | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 vaccination | |
| 650 | 4 | |a Greece | |
| 650 | 4 | |a Refugees and migrants | |
| 650 | 4 | |a Vaccine roll-out | |
| 650 | 4 | |a Vaccine uptake | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Giannakou, V |e verfasserin |4 aut | |
| 700 | 1 | |a Veizis, A |e verfasserin |4 aut | |
| 700 | 1 | |a Bougioukas, K |e verfasserin |4 aut | |
| 700 | 1 | |a Hargreaves, S |e verfasserin |4 aut | |
| 700 | 1 | |a Benos, A |e verfasserin |4 aut | |
| 700 | 1 | |a Kondilis, E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Public health |d 1945 |g 229(2024) vom: 23. März, Seite 84-87 |w (DE-627)NLM000433977 |x 1476-5616 |7 nnns |
| 773 | 1 | 8 | |g volume:229 |g year:2024 |g day:23 |g month:03 |g pages:84-87 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.puhe.2024.01.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 229 |j 2024 |b 23 |c 03 |h 84-87 | ||